With several new fast-acting insulins on the market, is it still necessary to pre-bolus before meals? How fast-acting are they really? Endocrinologist and type 1 Dr. Jeremy Pettus compares, contrasts, and gives his vote.
read more →
Many people with type 2 diabetes have fears about starting insulin therapy, but using inhaled insulin, one of the newest insulin options, may get around some of these fears. One thing is for sure, using ANY type of insulin will help control your diabetes and does not represent a failure on your part! Diabetes is a progressive disease, and at least a third of people with type 2 diabetes will eventually need insulin.
read more →
We all have them…mistakes we’ve made that we don’t even want to share with our own mother. Dr. Jeremy Pettus puts it all out there and gets real about what recently happened when he took the right dose of the wrong insulin.
read more →
Did you know CGMs come out of the box with their repeat low alerts set to “off”?
CGM’s are life-changing and life-saving. Learn how to make the most of yours, and use those bells and whistles to your advantage!
Achieving glucose goals is a critical part of overall diabetes management. The better the glucose control the lower the risk of long-term complications . Taking two or more glucose-lowering medications is usually needed in people with type 2 diabetes to achieve normal or near-normal glucose control.
read more →
The pain of insulin injections is well-documented, and the diabetes community is always searching for better alternatives. One such promising technology is the long-awaited OneTouch Via, an insulin patch pump from Johnson & Johnson subsidiary Calibra Medical.
read more →
So you’ve read all the headlines about an artificial pancreas and how it’s supposed to change the world for diabetes, but what does it really mean? We understand the skepticism… Remember: Medtronic previously claimed to have released an artificial pancreas system back in 2013.
read more →The diabetes community has been set ablaze after UnitedHealthcare announced an agreement for Medtronic devices to be the “preferred” in-network, durable medical equipment (DME) provider of insulin pumps. Starting July 1, 2016, UnitedHealthcare patients will be funneled toward using a Medtronic insulin pump instead of offerings from manufacturers like Tandem and Animas.
read more →On Tuesday, Mannkind announced that Sanofi will no longer market and distribute inhaled insulin Afrezza, effectively ending any current long-term plans for availability on pharmacy shelves (Mannkind plans to continue marketing the product, potentially with a new partner).
read more →
